BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2425894)

  • 1. Morphine and norepinephrine but not 5-hydroxytryptamine and gamma-aminobutyric acid inhibit the potassium-stimulated release of substance P from rat spinal cord slices.
    Pang IH; Vasko MR
    Brain Res; 1986 Jun; 376(2):268-79. PubMed ID: 2425894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gamma-Aminobutyric acid inhibits the potassium-stimulated release of somatostatin from rat spinal cord slices.
    Vasko MR; Harris V
    Brain Res; 1990 Jan; 507(1):129-37. PubMed ID: 1967972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine analogs do not inhibit the potassium-stimulated release of substance P from rat spinal cord slices.
    Vasko MR; Ono H
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):441-6. PubMed ID: 1701522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prenatal morphine and adult estrogen administration on mu-opioid inhibition of norepinephrine release from hypothalamic slices.
    Vathy I; Etgen AM
    Neuroendocrinology; 1996 Jan; 63(1):61-8. PubMed ID: 8839356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of morphine on the potassium evoked release of tritiated 5-hydroxytryptamine from spinal cord slices in the rat.
    Bineau-Thurotte M; Godefroy F; Weil-Fugazza J; Besson JM
    Brain Res; 1984 Jan; 291(2):293-9. PubMed ID: 6697192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of substance P release from the intermediate area of rat thoracic spinal cord.
    Yang L; Thomas ND; Helke CJ
    Synapse; 1996 Aug; 23(4):265-73. PubMed ID: 8855511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P-induced long-term blockade of spinal adrenergic analgesia: reversal by morphine and naloxone.
    Nance PW; Sawynok J
    J Pharmacol Exp Ther; 1987 Mar; 240(3):972-7. PubMed ID: 2435888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptidergic inhibitory regulation of Met-enkephalin immunoreactive material release from rat spinal cord in vitro.
    Uzumaki U; Govoni S; Faccini E; Pasinetti G; Missale C; Trabucchi M
    Peptides; 1984; 5(5):849-52. PubMed ID: 6209687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-aminobutyric acidA (GABAA) receptor modulation of morphine inhibition of norepinephrine release.
    Peoples RW; Giridhar J; Isom GE
    Biochem Pharmacol; 1991 Dec; 42 Suppl():S121-6. PubMed ID: 1662949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P enhances the release of endogenous serotonin from rat ventral spinal cord.
    Franck J; Fried G; Brodin E
    Eur J Pharmacol; 1989 Dec; 174(1):85-90. PubMed ID: 2482192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro.
    Ray NJ; Jones AJ; Keen P
    Br J Pharmacol; 1991 Apr; 102(4):797-800. PubMed ID: 1713104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neuroactive peptides on labeled 5-hydroxytryptamine release from rat spinal slices in vitro.
    Tsai HY; Maeda S; Iwatsubo K; Inoki R
    Jpn J Pharmacol; 1984 Aug; 35(4):403-6. PubMed ID: 6209442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine produces a biphasic modulation of substance P release from cultured dorsal root ganglion neurons.
    Suarez-Roca H; Maixner W
    Neurosci Lett; 1995 Jul; 194(1-2):41-4. PubMed ID: 7478208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A local serotonergic component involved in the spinal antinociceptive action of morphine.
    Crisp T; Smith DJ
    Neuropharmacology; 1989 Oct; 28(10):1047-53. PubMed ID: 2554180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord.
    Sweeney MI; White TD; Sawynok J
    J Pharmacol Exp Ther; 1989 Jan; 248(1):447-54. PubMed ID: 2492344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-aminobutyric acidB, but not gamma-aminobutyric acidA receptor activation, inhibits electrically evoked substance P-like immunoreactivity release from the rat spinal cord in vitro.
    Malcangio M; Bowery NG
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1490-6. PubMed ID: 7690402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.
    Iverfeldt K; Peterson LL; Brodin E; Ogren SO; Bartfai T
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):1-6. PubMed ID: 2426604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception.
    Skilling SR; Smullin DH; Larson AA
    J Neurosci; 1990 Apr; 10(4):1309-18. PubMed ID: 1691775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recurrent withdrawal on spinal GABA release during chronic morphine infusion in the rat.
    Dunbar SA; Karamian I; Yeatman A; Zhang J
    Eur J Pharmacol; 2006 Mar; 535(1-3):152-6. PubMed ID: 16540107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.